LAZARD ASSET MANAGEMENT LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$307
+429.3%
19,406
+27.4%
0.00%
Q1 2023$58
-100.0%
15,232
-48.2%
0.00%
Q2 2022$132,000
+109.5%
29,389
+161.1%
0.00%
Q3 2021$63,000
+34.0%
11,256
+93.8%
0.00%
Q1 2021$47,000
-93.5%
5,807
-92.1%
0.00%
-100.0%
Q2 2018$718,000
-7.5%
73,8580.0%0.00%0.0%
Q1 2018$776,000
+108.6%
73,858
+27.2%
0.00%0.0%
Q4 2017$372,00058,0860.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders